Workflow
Collgene
icon
Search documents
巨子生物跌超5% 中期业绩披露在即 此前负面舆论拖累618大促表现
Zhi Tong Cai Jing· 2025-08-27 06:06
巨子生物(02367)跌超5%,截至发稿,跌5.7%,报54.6港元,成交额5.6亿港元。 消息面上,巨子生物今日将举行董事会会议批准2025年中期业绩。招商证券国际此前指出,媒体负面舆 论拖累618大促表现,5–6月GMV同比增速放缓至中单位数百分比。该行预计公司25年上半年实现收入/ 净利润31/12亿元人民币,主要受益于Comfy与Collgene分别录得约25%与50%以上的销售增长。目标价 维持在77.0元港币不变。财通证券(601108)认为,可复美7月恢复达播后数据环比回暖,下半年销售 逐步回升可期。 ...
港股异动 | 巨子生物(02367)跌超5% 中期业绩披露在即 此前负面舆论拖累618大促表现
智通财经网· 2025-08-27 06:01
消息面上,巨子生物今日将举行董事会会议批准2025年中期业绩。招商证券国际此前指出,媒体负面舆 论拖累618大促表现,5–6月GMV同比增速放缓至中单位数百分比。该行预计公司25年上半年实现收入/ 净利润31/12亿元人民币,主要受益于Comfy与Collgene分别录得约25%与50%以上的销售增长。目标价 维持在77.0元港币不变。财通证券认为,可复美7月恢复达播后数据环比回暖,下半年销售逐步回升可 期。 智通财经APP获悉,巨子生物(02367)跌超5%,截至发稿,跌5.7%,报54.6港元,成交额5.6亿港元。 ...
高盛:巨子生物-2025 年上半年前瞻_ 尽管近期不确定性冲击销售,韧性利润率驱动净利润增长 20%;买入评级
Goldman Sachs· 2025-07-16 00:55
Investment Rating - The report maintains a "Buy" rating for Giant Biogene Holding (2367.HK) with a 12-month price target of HK$71.00, indicating a potential upside of 25.1% from the current price of HK$56.75 [1][15][34]. Core Insights - Giant Biogene is expected to achieve a year-on-year sales growth of 23% to RMB3,116 million and a net income growth of 20% to RMB1,183 million for 1H25, with an adjusted net profit of RMB1,205 million, reflecting a 17% increase year-on-year when excluding ESOP expenses [1][18][20]. - The company is positioned to benefit from the upcycle in China's functional skincare market, leveraging its strengths in recombinant collagen and expanding its online presence through key brands Comfy and Collgene [37][38]. Summary by Sections Financial Performance - Revenue forecasts for 2025-2027 have been revised upwards by 0-2% due to more resilient margins and faster sales recovery than previously estimated [15][34]. - The expected gross profit margin (GPM), operating profit margin (OPM), and net profit margin (NPM) for 1H25 are projected at 81.7%, 41.3%, and 38.0% respectively [25][26]. Market Trends - Online gross merchandise volume (GMV) has shown a recovery trajectory, increasing by 58% year-on-year on Douyin as of July, significantly outperforming peers [2][31]. - The report highlights a minimal contribution from KOL livestreaming, which accounted for approximately 10% of sales on Douyin in July, down from 20% in the same period last year [2]. Brand Performance - The Comfy brand is anticipated to deliver 21% growth in online sales and 16% growth in offline sales for 1H25, while the Collgene brand is expected to grow by 70% online but decline by 5% offline [23][28]. - The report emphasizes the company's strategies to revitalize brand momentum, particularly in preparation for the Double 11 shopping festival [2].